Company Search:
Advanced Search
Sponsored Links
Transgene Company Snapshot
Transgene operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Transgene with three other pharmaceutical manufacturers in Europe: Erytech Pharma SA (2016 sales of 4.14 million Euro [US$4.47 million] ), Curasan AG of Germany (6.94 million Euro [US$7.49 million] ), and Byotrol PLC which is based in the United Kingdom (£2.65 million [US$3.31 million] of which 54% was Professional).

Sales Analysis. During the year ended December of 2016, sales at Transgene were 10.31 million Euro (US$11.13 million). This is an increase of 7.8% versus 2015, when the company's sales were 9.57 million Euro. Despite this increase, sales are still below the level achieved in 2014, when Transgene reported sales of 11.75 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for Transgene
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 2.59
(Figures in Euro)
1 Week -1.9%   13 Weeks -3.0%  
4 Weeks -3.4%   52 Weeks -1.7%  
Transgene Key Data:
  Ticker: TNG Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 10,311,000
(Year Ending Jan 2017).
Employees: 266
  Currency: Euro Market Cap: 101,973,929
  Fiscal Yr Ends: December Shares Outstanding: 39,372,173
  Share Type: Actions Ordinaires Closely Held Shares: 35,747,838
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.